Annual EBIT
-$28.81 M
+$33.39 M+53.69%
December 31, 2023
Summary
- As of February 7, 2025, PRQR annual earnings before interest & taxes is -$28.81 million, with the most recent change of +$33.39 million (+53.69%) on December 31, 2023.
- During the last 3 years, PRQR annual EBIT has risen by +$21.95 million (+43.25%).
- PRQR annual EBIT is now -574.70% below its all-time high of -$4.27 million, reached on December 31, 2013.
Performance
PRQR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$9.74 M
-$5.69 M-140.78%
September 1, 2024
Summary
- As of February 7, 2025, PRQR quarterly earnings before interest & taxes is -$9.74 million, with the most recent change of -$5.69 million (-140.78%) on September 1, 2024.
- Over the past year, PRQR quarterly EBIT has dropped by -$1.69 million (-21.01%).
- PRQR quarterly EBIT is now -780.43% below its all-time high of $1.43 million, reached on December 31, 2015.
Performance
PRQR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$23.65 M
-$1.69 M-7.70%
September 1, 2024
Summary
- As of February 7, 2025, PRQR TTM earnings before interest & taxes is -$23.65 million, with the most recent change of -$1.69 million (-7.70%) on September 1, 2024.
- Over the past year, PRQR TTM EBIT has increased by +$10.55 million (+30.86%).
- PRQR TTM EBIT is now -1922.96% below its all-time high of -$1.17 million, reached on September 30, 2013.
Performance
PRQR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
PRQR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +53.7% | -21.0% | +30.9% |
| 3 y3 years | +43.3% | +51.4% | +68.5% |
| 5 y5 years | +32.7% | +51.4% | +68.5% |
PRQR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +57.5% | -787.3% | +51.4% | -7.7% | +68.5% |
| 5 y | 5-year | at high | +57.5% | -787.3% | +51.4% | -7.7% | +68.5% |
| alltime | all time | -574.7% | +57.5% | -780.4% | +51.4% | -1923.0% | +68.5% |
ProQR Therapeutics NV EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$9.74 M(+140.8%) | -$23.65 M(+7.7%) |
| Jun 2024 | - | -$4.04 M(-53.9%) | -$21.96 M(-20.3%) |
| Mar 2024 | - | -$8.77 M(+699.3%) | -$27.56 M(-4.5%) |
| Dec 2023 | -$28.81 M(-53.7%) | -$1.10 M(-86.4%) | -$28.88 M(-15.6%) |
| Sep 2023 | - | -$8.05 M(-16.6%) | -$34.20 M(-26.0%) |
| Jun 2023 | - | -$9.65 M(-4.3%) | -$46.20 M(-13.7%) |
| Mar 2023 | - | -$10.08 M(+57.0%) | -$53.52 M(-14.5%) |
| Dec 2022 | -$62.20 M(-8.2%) | -$6.42 M(-68.0%) | -$62.56 M(-16.7%) |
| Sep 2022 | - | -$20.04 M(+18.1%) | -$75.10 M(+3.5%) |
| Jun 2022 | - | -$16.97 M(-11.3%) | -$72.55 M(+0.8%) |
| Mar 2022 | - | -$19.13 M(+0.9%) | -$71.99 M(+6.7%) |
| Dec 2021 | -$67.77 M(+33.5%) | -$18.96 M(+8.3%) | -$67.45 M(+4.0%) |
| Sep 2021 | - | -$17.50 M(+6.7%) | -$64.89 M(+7.5%) |
| Jun 2021 | - | -$16.41 M(+12.5%) | -$60.38 M(+5.5%) |
| Mar 2021 | - | -$14.58 M(-11.0%) | -$57.23 M(-5.9%) |
| Dec 2020 | -$50.76 M(-18.3%) | -$16.39 M(+26.1%) | -$60.83 M(+1.5%) |
| Sep 2020 | - | -$13.00 M(-1.9%) | -$59.94 M(-3.2%) |
| Jun 2020 | - | -$13.25 M(-27.1%) | -$61.89 M(-0.1%) |
| Mar 2020 | - | -$18.19 M(+17.3%) | -$61.94 M(+2.4%) |
| Dec 2019 | -$62.17 M | -$15.50 M(+3.7%) | -$60.49 M(+1.4%) |
| Sep 2019 | - | -$14.95 M(+12.5%) | -$59.63 M(+15.7%) |
| Jun 2019 | - | -$13.30 M(-20.6%) | -$51.56 M(+6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$16.74 M(+14.4%) | -$48.58 M(+9.0%) |
| Dec 2018 | -$42.83 M(-12.2%) | -$14.64 M(+112.7%) | -$44.56 M(+0.3%) |
| Sep 2018 | - | -$6.88 M(-33.3%) | -$44.43 M(-9.8%) |
| Jun 2018 | - | -$10.32 M(-18.9%) | -$49.28 M(-2.0%) |
| Mar 2018 | - | -$12.72 M(-12.3%) | -$50.28 M(+3.5%) |
| Dec 2017 | -$48.78 M(+14.3%) | -$14.51 M(+23.7%) | -$48.57 M(+15.2%) |
| Sep 2017 | - | -$11.73 M(+3.6%) | -$42.18 M(+0.5%) |
| Jun 2017 | - | -$11.32 M(+2.8%) | -$41.97 M(-1.7%) |
| Mar 2017 | - | -$11.01 M(+35.6%) | -$42.71 M(+3.0%) |
| Dec 2016 | -$42.68 M(+88.2%) | -$8.12 M(-29.5%) | -$41.47 M(+29.9%) |
| Sep 2016 | - | -$11.52 M(-4.5%) | -$31.92 M(+11.3%) |
| Jun 2016 | - | -$12.06 M(+23.5%) | -$28.69 M(+20.7%) |
| Mar 2016 | - | -$9.77 M(-782.7%) | -$23.76 M(+8.1%) |
| Dec 2015 | -$22.68 M(+43.8%) | $1.43 M(-117.3%) | -$21.98 M(-7.9%) |
| Sep 2015 | - | -$8.29 M(+16.2%) | -$23.86 M(+8.5%) |
| Jun 2015 | - | -$7.13 M(-10.7%) | -$21.98 M(+2.5%) |
| Mar 2015 | - | -$7.99 M(+1687.5%) | -$21.44 M(+34.0%) |
| Dec 2014 | -$15.77 M(+269.4%) | -$447.10 K(-93.0%) | -$16.00 M(-8.9%) |
| Sep 2014 | - | -$6.41 M(-2.8%) | -$17.56 M(+42.5%) |
| Jun 2014 | - | -$6.59 M(+158.7%) | -$12.32 M(+115.2%) |
| Mar 2014 | - | -$2.55 M(+26.9%) | -$5.73 M(+80.2%) |
| Dec 2013 | -$4.27 M | -$2.01 M(+71.7%) | -$3.18 M(+171.7%) |
| Sep 2013 | - | -$1.17 M | -$1.17 M |
FAQ
- What is ProQR Therapeutics NV annual earnings before interest & taxes?
- What is the all time high annual EBIT for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV annual EBIT year-on-year change?
- What is ProQR Therapeutics NV quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV quarterly EBIT year-on-year change?
- What is ProQR Therapeutics NV TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV TTM EBIT year-on-year change?
What is ProQR Therapeutics NV annual earnings before interest & taxes?
The current annual EBIT of PRQR is -$28.81 M
What is the all time high annual EBIT for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high annual earnings before interest & taxes is -$4.27 M
What is ProQR Therapeutics NV annual EBIT year-on-year change?
Over the past year, PRQR annual earnings before interest & taxes has changed by +$33.39 M (+53.69%)
What is ProQR Therapeutics NV quarterly earnings before interest & taxes?
The current quarterly EBIT of PRQR is -$9.74 M
What is the all time high quarterly EBIT for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high quarterly earnings before interest & taxes is $1.43 M
What is ProQR Therapeutics NV quarterly EBIT year-on-year change?
Over the past year, PRQR quarterly earnings before interest & taxes has changed by -$1.69 M (-21.01%)
What is ProQR Therapeutics NV TTM earnings before interest & taxes?
The current TTM EBIT of PRQR is -$23.65 M
What is the all time high TTM EBIT for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high TTM earnings before interest & taxes is -$1.17 M
What is ProQR Therapeutics NV TTM EBIT year-on-year change?
Over the past year, PRQR TTM earnings before interest & taxes has changed by +$10.55 M (+30.86%)